TR201619184A2 - Donepezi̇l ve memanti̇n i̇çeren kapsül bi̇leşi̇mleri̇ - Google Patents

Donepezi̇l ve memanti̇n i̇çeren kapsül bi̇leşi̇mleri̇ Download PDF

Info

Publication number
TR201619184A2
TR201619184A2 TR2016/19184A TR201619184A TR201619184A2 TR 201619184 A2 TR201619184 A2 TR 201619184A2 TR 2016/19184 A TR2016/19184 A TR 2016/19184A TR 201619184 A TR201619184 A TR 201619184A TR 201619184 A2 TR201619184 A2 TR 201619184A2
Authority
TR
Turkey
Prior art keywords
donepesil
containing capsules
memantine
memantine containing
pharmaceutically acceptable
Prior art date
Application number
TR2016/19184A
Other languages
English (en)
Inventor
Türkyilmaz Ali̇
Yildirim Edi̇z
Muratoğlu Yeşi̇m
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2016/19184A priority Critical patent/TR201619184A2/tr
Priority to PCT/EP2017/084130 priority patent/WO2018115300A1/en
Priority to EP17209510.1A priority patent/EP3338767A1/en
Publication of TR201619184A2 publication Critical patent/TR201619184A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş, donepezil veya onun farmasötik olarak kabul edilebilir bir tuzunu, memantin veya onun farmasötik olarak kabul edilebilir bir tuzu ile kombinasyon halinde içeren bir kapsül dozaj formu ile ilgilidir.
TR2016/19184A 2016-12-22 2016-12-22 Donepezi̇l ve memanti̇n i̇çeren kapsül bi̇leşi̇mleri̇ TR201619184A2 (tr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2016/19184A TR201619184A2 (tr) 2016-12-22 2016-12-22 Donepezi̇l ve memanti̇n i̇çeren kapsül bi̇leşi̇mleri̇
PCT/EP2017/084130 WO2018115300A1 (en) 2016-12-22 2017-12-21 Capsule compositions comprising donepezil and memantine
EP17209510.1A EP3338767A1 (en) 2016-12-22 2017-12-21 Capsule compositions comprising donepezil and memantine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2016/19184A TR201619184A2 (tr) 2016-12-22 2016-12-22 Donepezi̇l ve memanti̇n i̇çeren kapsül bi̇leşi̇mleri̇

Publications (1)

Publication Number Publication Date
TR201619184A2 true TR201619184A2 (tr) 2018-07-23

Family

ID=60781854

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2016/19184A TR201619184A2 (tr) 2016-12-22 2016-12-22 Donepezi̇l ve memanti̇n i̇çeren kapsül bi̇leşi̇mleri̇

Country Status (3)

Country Link
EP (1) EP3338767A1 (tr)
TR (1) TR201619184A2 (tr)
WO (1) WO2018115300A1 (tr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109833309A (zh) * 2019-02-25 2019-06-04 山东省药学科学院 美金刚缓释微片胶囊及其制备方法
EP3760956B1 (de) 2019-07-04 2023-08-30 Ivoclar Vivadent AG Dentalofen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1509232B1 (en) 2002-05-31 2008-11-19 H. Lundbeck A/S A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease
US7619007B2 (en) * 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
US20110251239A1 (en) 2010-04-07 2011-10-13 Eisai Inc. Combination therapy for the treatment of dementia
CN105326837A (zh) * 2015-10-09 2016-02-17 北京万全德众医药生物技术有限公司 一种盐酸美金刚缓释-多奈哌齐速释复方胶囊

Also Published As

Publication number Publication date
EP3338767A1 (en) 2018-06-27
WO2018115300A1 (en) 2018-06-28

Similar Documents

Publication Publication Date Title
DOP2017000306A (es) Formulaciones farmacéuticas que contienen tenofovir y emtricitabina
MX2020012132A (es) Compuestos de azapiridona y usos de los mismos.
MX2017001512A (es) Compuestos activos hacia bromodominios.
MX2017016802A (es) Formulaciones farmaceuticas.
EA201692043A1 (ru) Лекарственная форма иммунодепрессанта
CL2018003338A1 (es) Formulaciones inyectables fisiológicamente balanceadas de fosnetupitant.
EA201890828A1 (ru) Оптимизированная таблетка с высокой дозой активного соединения, содержащая месалазин
AR090073A1 (es) N-etil-n-fenil-1,2-dihidro-4,5-di-hidroxi-1-metil-2-oxo-3-quinolinacarboxamida, su preparacion y usos
EA201991265A1 (ru) Лекарственные формы с отсроченным высвобождением, содержащие диметилфумарат
SI3362094T1 (sl) Kombinacija, ki obsega aminotiolestrsko spojino ali njeno farmacevtsko sprejemljivo sol in spojino, ki je sposobna povišati nivo H2O2 v rakavih celicah subjekta
TR201914043A1 (tr) Dapagli̇flozi̇n ve metformi̇n i̇çeren efervesan tablet formülasyonlari
CY1122979T1 (el) Φαρμακευτικη συνθεση για τη θεραπεια της μυκητιασης
EA201890477A1 (ru) Инкапсулированная композиция финголимода
EP3697393A4 (en) DOSAGE FORMS
EA201991007A1 (ru) Твердые фармацевтические композиции на основе гидрохлорида луразидона для перорального применения
EA201691422A1 (ru) Перорально распадающиеся таблетированные составы мемантина
MY203254A (en) Pharmaceutical preparation
PH12017501982A1 (en) Pharmaceutical compound
MY199020A (en) Pharmaceutical combination preparation
UA113442C2 (xx) Ентеросорбент
TR201818864A2 (tr) Di̇meti̇l fumarat ve en az bi̇r anti̇-epi̇lepti̇k ajan i̇çeren bi̇r kombi̇nasyon
UA112089C2 (uk) Тверда лікарська форма комбінованого препарату седативної та снодійної дії, що містить доксиламін
CR20170601A (es) Formulaciones farmaceuticas que comprenden tenofovir y emtricitabina
吉佳莉 Self-Exile of Female Characters in Salman Rushdie's Shame
CY1119636T1 (el) Φαρμακευτικο παρασκευασμα με βαση διοσμεκτιτη